CAVA
CAVA Group, Inc.
CAVA has lower modeled downside risk, despite its lower overall score.
RIVN
Rivian Automotive, Inc.
RIVN has the edge over CAVA overall, supported by stronger valuation.
CAVA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Strong |
CAVA's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
RIVN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
RIVN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CAVA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 53x | $28.53 | -50% |
| Fair | 75x | $40.72 | -29% |
| Forward | 84x | $57.35 | — |
| Current | 106x | $57.35 | — |
| Expensive | 147x | $79.57 | +39% |
Historical ranges are pointers, not guarantees.
CAVA's PE is in its fair range at 106x. If earnings grow as analysts expect, today's price would be 84x next year's earnings.
RIVN PE Valuation
RIVN has no meaningful PE right now: it lost money over the past year.
CAVA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect strong earnings and revenue growth for CAVA, with profitability improving. However, they disagree widely on these estimates.
RIVN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RIVN's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
CAVA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.69 | +27% |
| Q3 2026 | $0.54 | -53% |
| Q2 2026 | $0.55 | -54% |
| Q2 2026 | $0.52 | -57% |
| Q4 2025 | $0.54 | -51% |
CAVA has the edge over RIVN on earnings quality, reporting a profit while its opponent remains loss making.
RIVN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.25 | +$0.83 |
| Q2 2026 | -$2.58 | +$0.62 |
| Q1 2026 | -$2.92 | +$0.77 |
| Q4 2025 | -$3.07 | +$1.62 |
| Q3 2025 | -$3.08 | +$2.52 |
| Q2 2025 | -$3.20 | +$2.76 |
| Q1 2025 | -$3.69 | +$2.08 |
| Q4 2024 | -$4.69 | +$1.05 |
RIVN is still losing money, but far less than before: $2.25 per share over the past year, against $7.40 at its worst in late 2022.
CAVA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $356.4M | +22% |
| Q2 2026 | $368.4M | +31% |
| Q2 2026 | $438.3M | +32% |
| Q4 2025 | $275M | +21% |
| Q3 2025 | $292.2M | +20% |
| Q2 2025 | $280.6M | +20% |
| Q2 2025 | $331.8M | +28% |
| Q4 2024 | $227.4M | +28% |
CAVA has the edge over RIVN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 4.2% | -1.7 points |
| Q2 2026 | 7.3% | +0.3 points |
| Q2 2026 | 5.8% | +1 points |
| Q4 2025 | 1% | -0.7 points |
| Q3 2025 | 5.9% | +0.2 points |
| Q2 2025 | 7% | +0.1 points |
| Q2 2025 | 4.7% | +1.2 points |
| Q4 2024 | 1.7% | +2.6 points |
CAVA has the edge over RIVN on profitability, with a higher operating margin.
RIVN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +38% |
| Q2 2026 | $1.7B | +27% |
| Q1 2026 | $1.4B | +11% |
| Q4 2025 | $1.3B | -26% |
| Q3 2025 | $1.6B | +78% |
| Q2 2025 | $1.3B | +13% |
| Q1 2025 | $1.2B | +3% |
| Q4 2024 | $1.7B | +32% |
RIVN's revenue is growing: $2.2B last quarter, up 38% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +22 points |
| Q2 2026 | -50% | +35 points |
| Q1 2026 | -64% | -11 points |
| Q4 2025 | -65% | -27 points |
| Q3 2025 | -63% | +71 points |
| Q2 2025 | -86% | +33 points |
| Q1 2025 | -53% | +70 points |
| Q4 2024 | -38% | +82 points |
RIVN's operating margin was −41% last quarter, up 22 points from the same quarter a year ago, near the top of its range since 2021.
CAVA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.7M | -661% |
| Q2 2026 | $29.3M | +53% |
| Q2 2026 | $15.5M | +473% |
| Q4 2025 | $2.9M | +36% |
| Q3 2025 | $1.4M | -94% |
| Q2 2025 | $19.2M | -15% |
| Q2 2025 | $2.7M | -42% |
| Q4 2024 | $2.1M | +$9.3M |
CAVA has the edge over RIVN on cash generation, producing positive trailing cash flow while its opponent burns cash.
RIVN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.1B | -$703M |
| Q2 2026 | -$849M | -$451M |
| Q1 2026 | -$1.1B | -$549M |
| Q4 2025 | -$1.1B | -234% |
| Q3 2025 | -$421M | +$732M |
| Q2 2025 | -$398M | +$639M |
| Q1 2025 | -$526M | +$997M |
| Q4 2024 | $856M | +$2.3B |
RIVN has burned cash in almost every quarter: −$4.2B over the past year, against −$489M the year before.
CAVA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -93K shares |
| 1 year | 0% | +15K shares |
| 3 years | +278% | +87M shares |
CAVA has the edge over RIVN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2023 | $1.5M |
| Q3 2023 | $105,000 |
| Q2 2023 | $1.4M |
| Q4 2022 | $250,000 |
| Q3 2022 | $19,000 |
| Q2 2022 | $13,000 |
| Q2 2022 | $629,000 |
| Q4 2021 | $156,000 |
RIVN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +9.1% | +121M shares |
| 1 year | +19% | +226M shares |
| 3 years | +52% | +494M shares |
RIVN has 1.4B diluted shares, up 19% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | $6M |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CAVA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.9x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q2 2026 | -2.1x | Net Cash |
| Q4 2025 | -2.2x | Net Cash |
| Q3 2025 | -2.3x | Net Cash |
| Q2 2025 | -2.4x | Net Cash |
| Q2 2025 | -2.6x | Net Cash |
| Q4 2024 | -3.5x | Net Cash |
CAVA has more cash than debt.
RIVN Net Leverage
RIVN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CAVA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.6 | Neutral |
| Stochastic | 33.6 | Neutral |
CAVA's weekly RSI is 44 (neutral) and its Stochastic is 34 (neutral).
RIVN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.5 | Neutral |
| Stochastic | 25.6 | Neutral |
RIVN's weekly RSI is 41 (neutral) and its Stochastic is 26 (neutral).
CAVA PE vs Consumer Cyclical Sector
| Metric | CAVA | Sector median | Relative |
|---|---|---|---|
| PE | 106x | 18x | 489% above |
| PE % | 62 | 36 | 26 pts above |
CAVA is trading at 106x earnings, a 489% premium to the Consumer Cyclical sector's median of 18x.
RIVN PE vs Consumer Cyclical Sector
RIVN has no meaningful PE right now: it lost money over the past year.
CAVA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $55.7 | 3% above |
| 20 week MA | $61.8 | 7.2% below |
| 50 week MA | $69.9 | 18% below |
| 100 week MA | $77.2 | 26% below |
CAVA has stronger trend alignment. CAVA is above 1 of 4 weekly averages versus RIVN above 0 of 5.
RIVN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $13.3 | 3.9% below |
| 20 week MA | $15.1 | 15% below |
| 50 week MA | $15.9 | 19% below |
| 100 week MA | $14.7 | 13% below |
| 200 week MA | $15.1 | 15% below |
RIVN is in a downtrend: it's below all five of its weekly moving averages, and 15% below its 200-week average.
CAVA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $38.2 | $43.0 | +13% |
| 2024 | $43.0 | $114.4 | +166% |
| 2025 | $114.4 | $60.2 | -47% |
| 2026 YTD | $60.2 | $57.4 | -4.7% |
CAVA has the edge over RIVN on returns for 2026, with the stronger performance.
RIVN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $130.0 | $96.8 | -25% |
| 2022 | $96.8 | $19.1 | -80% |
| 2023 | $19.1 | $23.5 | +23% |
| 2024 | $23.5 | $13.7 | -42% |
| 2025 | $13.7 | $20.9 | +53% |
| 2026 YTD | $20.9 | $12.8 | -39% |
RIVN has finished lower in three of the last five years. It's down 39% so far in 2026.